China Pharma Holdings (CPHI) Notes Payables (2010 - 2026)
China Pharma Holdings (CPHI) posted Notes Payables of $1.5 million for Q1 2026, up 2.16% on a QoQ basis from $1.4 million in Q4 2025, and up 27.12% year-over-year from $1.2 million in Q1 2025.
China Pharma Holdings (CPHI) Notes Payables (2010 - 2026) Analysis & Trends
China Pharma Holdings' Notes Payables history runs 12 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- Quarterly Notes Payables rose 27.12% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 27.12% YoY) and the FY2025 annual result came in at $1.4 million, up 25.34% from the prior year.
- Notes Payables was $1.5 million for Q1 2026 at China Pharma Holdings, up from $1.4 million in the prior quarter.
- Across five years, Notes Payables topped out at $4.6 million in Q3 2022 and bottomed at $315428.0 in Q3 2024.
- A 5-year average of $1.7 million and a median of $1.4 million in 2025 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables tumbled 84.44% — and 2025, when it surged 348.07%.
- China Pharma Holdings' Notes Payables stood at $3.8 million in 2022, then sank by 70.16% to $1.1 million in 2023, then rose by 0.99% to $1.1 million in 2024, then gained by 25.34% to $1.4 million in 2025, then advanced by 2.16% to $1.5 million in 2026.
- Business Quant data shows CPHI's Notes Payables at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 315,428.00 |
| Jun 30, 2024 | 410,415.00 |
| Mar 31, 2024 | 490,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Sep 30, 2016 | 2.25 Mn |
| Jun 30, 2016 | 4.52 Mn |
| Mar 31, 2016 | 4.65 Mn |
| Dec 31, 2015 | 4.62 Mn |
| Sep 30, 2015 | 4.72 Mn |